{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T16:16:08Z","timestamp":1743264968916,"version":"3.30.2"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":6817,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1997,1]]},"abstract":"<jats:sec><jats:title\/><jats:p><jats:bold>We analyzed the long\u2013term clinical course of 71 patients with RNA\u2013positive hepatitis C virus (HCV) infection after liver transplantation. Patients with reinfection after transplantation for HCV\u2013related liver disease, or de novo infection at transplantation were followed for up to 12 years. Cumulative survival for patients with HCV infection at 2, 5, and 10 years after transplantation was 67%, 62%, and 62%, respectively. It was not significantly different from that in patients transplanted for other nonmalignant diseases without HCV infection. The main factor determining long\u2013term survival was the presence or absence of hepatocellular carcinoma (HCC) at transplantation. The 5\u2013year survival rate for HCV patients with or without HCC was 35% versus 73%, respectively (P &lt; .05). No deaths because of viral hepatitis of the graft were observed. Deaths in the first year after transplantation were caused by infectious complications, cardiovascular problems, or rejection; deaths after more than 12 months were exclusively because of recurrence of HCC. Biochemical and histological evidence of hepatitis was found in the majority of the patients, only 16% had normal alanine aminotransferase (ALT) values throughout. Twenty\u2013two percent of patients complained of symptoms, with hepatitis C being the cause in 82% of these. Two patients lost their HCV\u2013RNA for prolonged, ongoing periods of time. The severity of the posttransplantation hepatitis was unrelated to age, sex, severity of liver disease before transplantation, cold ischemic time of the graft, duration of the operation, transfusions, the number of rejection episodes, or the long\u2013term immunosuppressive regime. Only initial short\u2013term therapy with interleukin 2 (IL2) receptor antibodies adversely influenced inflammatory activity. Viral genotype did not influence the course of the graft hepatitis in our series. Histology showed inflammation in 88% of the biopsies and signs of fibrosis in 24%. Mean ALT values correlated with inflammation but not with fibrosis in the biopsies. Porto\u2013portal bridging was observed in six patients, one patient developed cirrhosis within 2 years after orthotopic liver transplantation (OLT). We conclude that chronic hepatitis develops in the majority of patients with HCV infection after liver transplantation. Carrier states without significant laboratory abnormalities are observed in approximately 16%, biochemical abnormalities without symptoms are seen in 60%, and symptomatic disease develops in a quarter of the patients. The disease course closely resembles that seen in nontransplanted hepatitis C patients. It is generally mild but little over 10% of patients develop signs of fibrosis of the graft during the first decade.<\/jats:bold><\/jats:p><\/jats:sec>","DOI":"10.1002\/hep.510250137","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T23:03:48Z","timestamp":1090969428000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["Long\u2013Term Outcome of Hepatitis C Virus Infection After Liver Transplantation"],"prefix":"10.1097","volume":"25","author":[{"given":"K. H.","family":"B\u00f6ker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dalley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Maschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. L.","family":"Tillmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Oldhaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pichlmayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1002\/hep.510250137-BIB1|cit1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1007259","article-title":"Epidemiology of hepatitis C in the west","volume":"15","author":"Alter","year":"1995","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.510250137-BIB2|cit2","first-page":"155","article-title":"The detection, transmission, and outcome of hepatitis C virus infection","volume":"2","author":"Alter","year":"1993","journal-title":"Infect Agents Dis"},{"key":"10.1002\/hep.510250137-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team [Comments]","volume":"327","author":"Alter","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.510250137-BIB4|cit4","first-page":"2006","article-title":"Hepatitis C and B in liver transplantation","volume":"25","author":"Lake","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1002\/hep.510250137-BIB5|cit5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-2007-1007263","article-title":"Hepatitis C and hepatocellular carcinoma","volume":"15","author":"Bisceglie","year":"1995","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.510250137-BIB6|cit6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.1840130418","article-title":"Recurrence of hepatitis C virus infection after orthotopic liver transplantation [Comments]","volume":"13","author":"Martin","year":"1991","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.510250137-BIB7|cit7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0016-5085(92)91129-R","article-title":"Recurrent and acquired hepatitis C viral infection in liver transplant recipients","volume":"103","author":"Wright","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510250137-BIB8|cit8","first-page":"1137","article-title":"Hepatitis C virus reinfection in allografts after orthotopic liver transplantation","volume":"16","author":"Konig","year":"1992","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.510250137-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI115723","article-title":"Reinfection of liver graft by hepatitis C virus after liver transplantation","volume":"89","author":"Feray","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1002\/hep.510250137-BIB10|cit10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.1840160403","article-title":"Hepatitis C viral infection in liver transplant recipients","volume":"16","author":"Ferrell","year":"1992","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.510250137-BIB11|cit11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00007890-199402000-00009","article-title":"Biochemical and histological evaluation of recurrent hepatitis C following orthotopic liver transplantation","volume":"57","author":"Shiftman","year":"1994","journal-title":"Transplantation"},{"key":"10.1002\/hep.510250137-BIB12|cit12","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1002\/hep.1840200708","article-title":"Liver transplantation for hepatitis C virus related cirrhosis","volume":"20","author":"Asher","year":"1994","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.510250137-BIB13|cit13","first-page":"978A","article-title":"Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation [Abstract]","volume":"106","author":"Schluger","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510250137-BIB14|cit14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2007-1007266","article-title":"Hepatitis C in the setting of transplantation","volume":"15","author":"Terrault","year":"1995","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.510250137-BIB15|cit15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0168-8278(91)90869-D","article-title":"Liver transplantation in HBs antigen carriers: prevention of hepatitis B recurrence by passive immunization","volume":"13","author":"M\u00fcller","year":"1991","journal-title":"J Hepatol"},{"key":"10.1002\/hep.510250137-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/0016-5085(94)90417-0","article-title":"Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2","volume":"106","author":"Michitaka","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510250137-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1099\/0022-1317-74-6-1093","article-title":"Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay","volume":"74","author":"Stuyver","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1002\/hep.510250137-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1099\/0022-1317-73-5-1131","article-title":"Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants","volume":"73","author":"McOrmish","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1002\/hep.510250137-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM198910123211505","article-title":"Liver Transplantation","volume":"321","author":"Starzl","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.510250137-BIB20|cit20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-2007-1007380","article-title":"Terminology of hepatic allograft rejection","volume":"12","author":"Ludwig","year":"1992","journal-title":"Semin Liver Dis"},{"key":"10.1002\/hep.510250137-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/0016-5085(95)90207-4","article-title":"Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation","volume":"108","author":"Feray","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510250137-BIB22|cit22","first-page":"1","article-title":"Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features","volume":"22","author":"Gretch","year":"1995","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.510250137-BIB23|cit23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00007890-199502270-00036","article-title":"The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation","volume":"59","author":"Manez","year":"1995","journal-title":"Transplantation"},{"issue":"Suppl","key":"10.1002\/hep.510250137-BIB24|cit24","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1016\/0002-9343(94)90189-9","article-title":"Interferon treatment of chronic hepatitis C","volume":"96","author":"Davis","year":"1994","journal-title":"Am J Med"},{"key":"10.1002\/hep.510250137-BIB25|cit25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/hep.1840140603","article-title":"Long term clinical and histopathological follow up of chronic posttransfusion hepatitis","volume":"14","author":"Bisceglie","year":"1991","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.510250137-BIB26|cit26","first-page":"117","article-title":"Chronic hepatitis C","volume":"40","author":"Sherlock","year":"1994","journal-title":"Dis Mon"},{"key":"10.1002\/hep.510250137-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199212313272703","article-title":"Long term mortality after transfusion associated non-A, non-B hepatitis","volume":"327","author":"Seef","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1002\/hep.510250137-BIB28|cit28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840130402","article-title":"Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease","volume":"13","author":"Todo","year":"1991","journal-title":"HEPATOLOGY"},{"key":"10.1002\/hep.510250137-BIB29|cit29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-7091-5633-9_3","article-title":"Immune pathogenesis of hepatitis B","volume":"4","author":"Ferrari","year":"1992","journal-title":"Arch Virol Suppl"},{"issue":"suppl","key":"10.1002\/hep.510250137-BIB30|cit30","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/0168-8278(90)90170-V","article-title":"The hepatitis B virus and the host response","volume":"ll","author":"Thomas","year":"1990","journal-title":"J Hepatol"},{"key":"10.1002\/hep.510250137-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1172\/JCI117893","article-title":"Hepatitis C virus genotype, tissue HCV antigens, hepatocelular expression of HLA-A,B,C, and intercellular adhesion-1 molecules-clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic Hepatitis C","volume":"95","author":"Ballardini","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1002\/hep.510250137-BIB32|cit32","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(94)90759-5","article-title":"Quantitation of hepatitis C virus RNA in liver transplant recipients","volume":"106","author":"Chazouilleres","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510250137-BIB33|cit33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/hep.1840200402","article-title":"Interferon-alpha therapy for hepatitis C virus infection after liver transplantation","volume":"20","author":"Wright","year":"1994","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.510250137","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-199701000-00037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T01:46:07Z","timestamp":1734486367000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-199701000-00037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.510250137","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}